Finance

Lists
301333:SHE
R&G PharmaStudies Co Ltd
54,50 CN¥
-1,38%
(-0,76) 1D
19 қаз., 15:04:07 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301333...
Open
54,60 CN¥
High
55,68 CN¥
Low
51,28 CN¥
Mkt. cap
5,34 млрд
Avg. vol.
2,89 млн
Volume
2,19 млн
Dividend
0,29%
Quarterly dividend
0,04 CN¥
Ex-dividend date
2026 ж. 03 шіл.
P/E ratio
43,61
52-wk high
91,78 CN¥
52-wk low
43,79 CN¥
EPS
1,25 CN¥
Shares outstanding
96,58 млн
No. of employees
3 мың
Open
54,60 CN¥
High
55,68 CN¥
Low
51,28 CN¥
Mkt. cap
5,34 млрд
Avg. vol.
2,89 млн
Volume
2,19 млн
Dividend
0,29%
Quarterly dividend
0,04 CN¥
Ex-dividend date
2026 ж. 03 шіл.
P/E ratio
43,61
52-wk high
91,78 CN¥
52-wk low
43,79 CN¥
EPS
1,25 CN¥
Shares outstanding
96,58 млн
No. of employees
3 мың
News stories
From web sources and news partners
About R&G PharmaStudies Co Ltd
CEO-
Employees2,64 мың
Founded2008 ж. 22 там.
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
227,71 млн
243,64 млн
218,09 млн
249,87 млн
Cost of goods sold
153,16 млн
164,25 млн
152,25 млн
174,53 млн
Cost of revenue
153,16 млн
164,25 млн
152,25 млн
174,53 млн
Research and development expenses
15,10 млн
16,19 млн
15,51 млн
18,39 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22,99 млн
30,78 млн
23,05 млн
24,60 млн
Operating expense
38,00 млн
50,32 млн
39,67 млн
50,25 млн
Total operating expenses
191,16 млн
214,57 млн
191,92 млн
224,78 млн
Operating income
36,55 млн
29,07 млн
26,18 млн
25,09 млн
Other non operating income
-1,56 млн
1,43 млн
-3,03 млн
3,02 млн
EBT including unusual items
39,46 млн
45,33 млн
25,76 млн
24,43 млн
EBT excluding unusual items
40,16 млн
32,65 млн
26,20 млн
22,97 млн
Income tax expense
4,17 млн
3,87 млн
2,88 млн
1,95 млн
Effective tax rate
10,56%
8,54%
11,16%
7,97%
Other operating expenses
1,04 млн
1,05 млн
1,01 млн
1,30 млн
Net income
34,45 млн
41,33 млн
22,83 млн
21,64 млн
Net profit margin
15,13%
16,96%
10,47%
8,66%
Earnings per share
-
-
-
-
Interest and investment income
5,23 млн
6,24 млн
3,65 млн
1,47 млн
Interest expense
-623,53 м.
-623,36 м.
-605,42 м.
-567,67 м.
Net interest expenses
4,61 млн
5,62 млн
3,05 млн
906,53 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
38,49 млн
30,77 млн
27,88 млн
26,74 млн
Gain or loss from assets sale
-
9,34 мың
-
-3,52 мың
AI content may include mistakes. Learn more
Google қолданбалары